The Structure of Hypericin in Solution. Searching for Hypericin's 1,6 Tautomer ¶
暂无分享,去创建一个
[1] D. Meruelo,et al. Inhibition of the CD8+ T cell-mediated cytotoxicity reaction by hypericin: potential for treatment of T cell-mediated diseases. , 2000, International immunology.
[2] D. Meruelo,et al. Strategies for Evaluation of Enveloped Virus Inactivation in Red Cell Concentrates Using Hypericin , 2000, Photochemistry and photobiology.
[3] H. Falk,et al. Concerning the Association of Hypericin Tautomers and their Hypericinate Ions , 2000 .
[4] J. Petrich,et al. Exploring Ground-State Heterogeneity of Hypericin and Hypocrellin A and B: Dynamic and 2D ROESY NMR Study , 1999 .
[5] H. Falk,et al. A Structural Proof for the Hypericin 1,6-Dioxo Tautomer , 1999 .
[6] J. Petrich,et al. Temperature Dependence of the Excited-State Intramolecular Proton Transfer Reaction in Hypericin and Hypocrellin A , 1999 .
[7] H. Falk,et al. Concerning the Structural Complexity of Hypericin: The Relative Stabilities of Some Neutral and Deprotonated Tautomers , 1998 .
[8] Mark S. Gordon,et al. Structure and Energetics of Ground-State Hypericin: Comparison of Experiment and Theory , 1998 .
[9] P. Hildebrandt,et al. Vibrational spectroscopy of hypericin, its sodium salt and pyridinium complex , 1997 .
[10] George A. Kraus,et al. Hypericin, Hypocrellin, and Model Compounds: Primary Photoprocesses of Light-Induced Antiviral Agents , 1997 .
[11] Y. Cohen,et al. Complexes of Macrocycles with γ-Cyclodextrin As Deduced from NMR Diffusion Measurements , 1997 .
[12] H. Spreitzer,et al. Electron-Acceptor Properties of Hypericin and Its Salts: An ESR/ENDOR and Electrochemical Study , 1995 .
[13] H. Falk,et al. Synthesis and properties of fringelite D (1,3,4,6,8,10,11,13-octahydroxy-phenanthro[1,10,9,8,o,p,q,r,a]perylene-7,14-dione) , 1995 .
[14] P. Agostinis,et al. Photosensitized inhibition of growth factor-regulated protein kinases by hypericin. , 1995, Biochemical pharmacology.
[15] D. Meruelo,et al. The chemical and biological properties of hypericin—a compound with a broad spectrum of biological activities , 1995, Medicinal research reviews.
[16] R. Law,et al. Hypericin in adjuvant brain tumor therapy , 1995 .
[17] F. Frolow,et al. Acidic properties of hypericin and its octahydroxy analogue in the ground and excited states , 1994 .
[18] I. Yamazaki,et al. Excited‐State Properties of Hypericin (I): Electronic Spectra and Fluorescence Decay Kinetics. , 1993 .
[19] H. Falk,et al. On the tautomerism of hypericin: The 1,6-dioxo tautomer , 1993 .
[20] H. Falk,et al. Tautomerism and stereochemistry of hypericin: Force field, NMR, and X-ray crystallographic investigations , 1993 .
[21] H. Falk,et al. On the synthesis of hypericin by oxidative trimethylemodin anthrone and emodin anthrone dimerization: Isohypericin , 1992 .
[22] D. Weiner,et al. Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[23] D. Meruelo,et al. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[24] M. Sheves,et al. Alteration of pKa of the bacteriorhodopsin protonated Schiff base. A study with model compounds , 1986 .